531739 — Gennex Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.99bn
- IN₹2.04bn
- IN₹1.38bn
- 36
- 50
- 24
- 27
Annual cashflow statement for Gennex Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 50.6 | 52.8 | 63.7 | 165 | 214 |
| Depreciation | |||||
| Non-Cash Items | 6.9 | 17.8 | -13.1 | -7.19 | -59.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -80.7 | 40.7 | 177 | -648 | -282 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14.4 | 119 | 237 | -467 | -108 |
| Capital Expenditures | -0.788 | -15.9 | -398 | 0 | -89.5 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.538 | -8.72 | 14.6 | 189 | 97.7 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.25 | -24.7 | -383 | 189 | 8.24 |
| Financing Cash Flow Items | -7.44 | -8.77 | -13.5 | -30.8 | -36.1 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.2 | -18.3 | 210 | 737 | 45.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.57 | 76.1 | 63.8 | 459 | -54.1 |